Ostenil is a pharmaceutical-grade, isotonic solution of highly purified sodium hyaluronate, engineered for the management of pain and impaired mobility in synovial joints. This 1% concentration viscosupplement acts as a biomechanical lubricant and shock absorber, mimicking the rheological properties of healthy synovial fluid. By restoring the viscoelasticity of the joint space, Ostenil mitigates mechanical stress on the cartilage, suppresses inflammatory mediators, and stimulates the body’s endogenous production of hyaluronic acid.

Key Features

• High-Purity Sodium Hyaluronate: Derived through a specialized fermentation process, ensuring a non-animal, hypoallergenic formula with high biocompatibility.
• Optimized Viscosupplementation: Restores the lubrication and shock-absorbing capacity of the synovial fluid, significantly reducing friction between articular surfaces.
• Chondro-Protective Action: Helps protect the cartilage matrix from mechanical degradation and inhibits the activity of degradative enzymes within the joint capsule.
• Anti-Inflammatory Modulation: Aids in reducing joint effusion and pain by coating sensory nerve endings and regulating the movement of inflammatory cells.
• Sterile Prefilled Delivery: Packaged in a 2 ml prefilled syringe for immediate clinical use, ensuring a sterile environment and precise 20 mg dosage.

Recommended Usage

Ostenil is indicated for the treatment of symptoms of osteoarthritis in the knee, hip, or other synovial joints.

• Administration: This product must be administered via intra-articular injection by a qualified healthcare professional (Orthopedic surgeon, Rheumatologist, or Sports Medicine specialist).
• Treatment Protocol: A standard course typically consists of 3 to 5 injections, administered at weekly intervals. Multiple joints may be treated simultaneously.
• Duration of Effect: Relief from pain and improved joint function can last up to 6–12 months depending on the severity of the joint degeneration.
• Post-Injection Care: Patients are advised to avoid strenuous physical activity for 48 hours following the procedure.